U.S. News April 14, 2022
David Levine

Leaders are working together to address disparities and improve cardiovascular health for all.

“If significant changes are not made to curtail the rising incidence of cardiovascular disease, that burden is likely to overwhelm society,” especially among vulnerable populations, said Victor Bulto, head of U.S. Pharmaceuticals for Novartis Pharmaceuticals Corporation.

Heart disease has long been the No. 1 cause of death in the United States, accounting for approximately 1 in every 4 deaths each year, according to data from the Centers for Disease Control and Prevention. As with many health issues, heart disease can disproportionately affect certain demographic and socioeconomic groups, underscoring the sad adage that ZIP code is a primary risk factor for ill health.

“If significant changes are not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Healthcare System, Patient / Consumer, Population Health Mgmt, Provider
Longitude Health launches population health company
Systems Thinking: The Future of Equitable, Efficient, and Effective Population Health Management
Growing Demand for Population Health Tools in Asia-Pacific Highlighted in the 2025 Black Book of Global Healthcare IT
Alzheimer Disease Treatment Can Improve Population Health and Health Equity
Designing and Evaluating Interventions that have a Measurable Impact on Population Health through Evidence-Based Practices and Research

Share This Article